Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03542487 · ClinicalTrials.gov registry record · NA

Blood Glucose Monitoring in Electronic Health Records

A NA study of Diabetes Mellitus, sponsored by Inova Health Care Services.

Completed
Registry status
NA
Development phase
7,052
Enrollment target
1
Study location

NCT03542487: Completed NA study of Diabetes Mellitus, sponsored by Inova Health Care Services.

NCT03542487 is a NA study of Diabetes Mellitus that has completed, run by Inova Health Care Services. The registered enrollment target is 7,052 participants, above the 1,833-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (285% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03542487, a NA study of Diabetes Mellitus, has completed, sponsored by Inova Health Care Services.

COMPLETED
Registry status
NA
Development phase
7,052 participants
Enrollment target
1
Study location

Study Summary

This multi-site randomized tral aims to test methods of increasing adoption and integration of blood glucose monitoring into electronic medical records, and to measure the impact of wide-scale adoption on health status of patients with diabetes. To investigate determinants of adoption, the research will combine and test doctor and patient focused approaches to encouraging patient use of blood glucose flow sheets through the online patient portal, MyChart. Adoption will be measured on both the extensive and intensive margin: the number of patients who enter data into the flowsheets at all during the study period, and the mean number of entries per patient during the study period. Conditional on statistically significant increases in adoption, the study will examine corresponding intent-to-treat effects on patient A1c, and consider other indicators of possible mechanisms through which A1c improves or does not improve.

Primary Outcome

Count of participants that entered data to an electronic glucose flowsheet during the measurement period (Count of participants determined with a binary aggregation method; 1= Participant used Flow Sheet at least once during measurement period; 0= Participant did not use Flow Sheet during Measurement Period)

Conditions Studied

Interventions

  • BEHAVIORAL Practice Orientation
  • BEHAVIORAL Standard Reminder
  • BEHAVIORAL Gift Card Reminder
  • BEHAVIORAL Physician Reminders

Study Locations (1)

Virginia

  • Inova Heath System - Falls Church

Trial Details

FieldValue
Enrollment Target 7,052 participants
Start Date 2018-05-01
Est. Completion 2018-10-31
Phase NA
Inova Health Care Services

75 total trials

What the finished NCT03542487 record still lists

NCT03542487 is an interventional study that assigns participants to a tested intervention. Its 7,052 participants enrollment target places it among the larger protocols in the corpus, above the 1,833-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (285% higher).

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 4 interventions - of which Practice Orientation is the first listed.

NCT03542487 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT03542487 about?

NCT03542487 is a clinical study titled "Blood Glucose Monitoring in Electronic Health Records". This multi-site randomized tral aims to test methods of increasing adoption and integration of blood glucose monitoring into electronic medical records, and to measure the impact of wide-scale adoption on health status of patients with diabetes. To investigate determinants of adoption, the research ...

What is the current status of trial NCT03542487?

This trial is currently completed. It is a NA study. The enrollment target is 7,052 participants. The study started on 2018-05-01. Estimated completion is 2018-10-31.

What conditions does trial NCT03542487 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT03542487?

The interventions under investigation include: Practice Orientation (BEHAVIORAL), Standard Reminder (BEHAVIORAL), Gift Card Reminder (BEHAVIORAL), Physician Reminders (BEHAVIORAL).

Who is sponsoring clinical trial NCT03542487?

This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03542487 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03542487's enrollment target sits among peer trials

7,052 10th of 208 higher than 199 of 208 other Diabetes Mellitus trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06843720 · 7,100 participants · NA

    Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems

  • NCT00260585 · 7,000 participants

    Esophageal Cancer Risk Registry

  • NCT04118660 · 7,000 participants

    Thoracic Specimen Registry

  • NCT07106879 · 7,000 participants

    Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03542487, the US trial registry maintained by the National Library of Medicine. NCT03542487 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.